Company news
Evofem Biosciences, Inc. news in 2023
Evofem Biosciences, Inc.'s news releases, calls and decks from 2023, newest first.
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
December 11, 2023
Evofem Biosciences Announces Financial Results for the Third Quarter of 2023
November 13, 2023
Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023
October 23, 2023
Evofem to Participate in the Virtual Investor Ask the CEO Conference
October 12, 2023
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire
September 26, 2023
Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor
September 10, 2023
Evofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange
August 21, 2023
Evofem Biosciences Announces Financial Results for the Second Quarter of 2023
August 13, 2023
Evofem to Participate in the Virtual Investor Summer Spotlight Series
July 5, 2023
Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023
May 31, 2023
Evofem Biosciences Announces 1-for-125 Reverse Stock Split
May 16, 2023
Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update
April 27, 2023
Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary
April 13, 2023
Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required
April 11, 2023
Evofem Biosciences Announces Cost Reduction Measures
March 20, 2023
Evofem Biosciences Appoints Interim Chief Financial Officer
March 8, 2023
Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering
February 28, 2023
Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi
February 27, 2023
Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value
February 23, 2023
Evofem's Phexxi Contraceptive Gel to be Offered by Female Telehealth Leader Favor (Formerly The Pill Club)
January 12, 2023
Costco Adds Phexxi® to Member Prescription Program
January 10, 2023
Multiple New Insurance Wins Expand and Improve Access to Phexxi® for Millions of Women
January 9, 2023
Decks in 2023
- Investor Presentation (August 2023)
Investor deck · 16 slides · Aug 28, 2023